Use App
  • Trending
  • News
  • Earnings
DIADIA1.99%
SPYSPY1.87%
QQQQQQ3.51%
Trending
Top trending tickerADBEADBE11.94%
RDWRDW24.14%
ASTSASTS16.26%
SPACZZXSPACZZX0.60%
NASANASA18.12%
VELOVELO44.00%
SNDKSNDK16.11%
SATSSATS16.81%
PWRL28.34%
RHRH6.26%
Top trending tickerADBEADBE11.94%
RDWRDW24.14%
ASTSASTS16.26%
SPACZZXSPACZZX0.60%
NASANASA18.12%
VELOVELO44.00%
SNDKSNDK16.11%
SATSSATS16.81%
PWRL28.34%
RHRH6.26%
homeSymbolGNPX
GNPX logo

GNPXGenprex Inc

$0.665
$0.0175
(2.75%)
Today
·Closed $0.6536
$0.0114
(1.74%)
After Hours
Updated: 06:06 PM EDT
Reported EarningsAug 28
Mkt Cap$6.73M
Vol127,446.00

Fundamentals

Mkt Cap
$6.73M
Volume
-
52W High
$55.00
52W Low
$0.6342
PE Ratio
-0.04
Avg. Volume
311,094.11
EPS (Annual)
-$17.40
P/B
0.34
Rev/Employee
$0.00
Earnings
Aug 28

Feed

News

Sentiment

Earnings

Fundamentals

Info

Advertisement|Remove ads.

Latest GNPX News

View
Positive Clinical Data on Biomarkers in Patients Receiving Reqorsa Gene Therapy Published at the 2026 ASCO Annual Meeting
PR Newswire
News Placeholder
Genprex Collaborators Present Positive Preclinical Data on Diabetes Gene Therapy for Type 2 Diabetes at the 2026 American Society of Gene and Cell Therapy Annual Meeting
PR Newswire
News Placeholder
Genprex Receives Patent Grant from The Israel Patent Office for the Combination of Reqorsa Gene Therapy and PD-1 Antibodies to Treat Cancer
PR Newswire
News Placeholder
Loading...

Advertisement|Remove ads.

Advertisement|Remove ads.

TrendingNews
CommunityProfile